CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Open-market buy 10% owner bought 4,750,000 shares at $0.80 ($3,800,000)
- 4 Open-market buy 10% owner bought 5,000,000 shares at $0.80 ($4,000,000)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 4 Open-market buy President and CEO bought 37,500 shares at $0.80 ($30,000)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Director sold 10,000 shares at $1.10 ($11,000)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.26 ($6,292)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 10-K/A Report 10-K/A
- 4/A Grant or award Director acquired 45,455 shares (grant or award)
- 4/A Grant or award Director acquired 34,848 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 27 of 78 · 1,549 filings